The BHF announced today that the Big Beat challenge is awarded to CureHeart lead by Hugh Watkins.
CureHeart will seek to develop the first cures for inherited heart muscle diseases by pioneering revolutionary and ultra-precise gene therapy technologies that could edit or silence the faulty genes that cause these deadly conditions.
The BHF award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine. This global award, at £30m, is one of the largest non-commercial grants ever given and presents a “once in a generation opportunity” to provide hope for families struck by these killer diseases.
The VIAgenomics team is proud to have Hugh on board! Congratulations! Very well done!
A short explainer what CureHeart will deliver can be found here.